Abstract
The SARS coronavirus main proteinase is a prime target for antiviral therapy. In this issue of Chemistry & Biology, Wu et al. describe potent inhibition of the enzyme by benzotriazole esters, which were originally obtained as intermediates in the synthesis of lopinavir derivatives [1].
Original language | English |
---|---|
Journal | Chemistry and Biology |
Volume | 13 |
Issue number | 3 |
Pages (from-to) | 235-236 |
Number of pages | 2 |
ISSN | 1074-5521 |
DOIs | |
Publication status | Published - 01.03.2006 |
Research Areas and Centers
- Academic Focus: Center for Infection and Inflammation Research (ZIEL)
Coronavirus related work
- Research on SARS-CoV-2 / COVID-19